Blood and Marrow Transplant Program reaccredited by FACT
Todd F. Roberts, MD
The Roger Williams Medical Center Blood and Marrow Transplant program, the only unit of its kind in the state, has been awarded renewed accreditation from the Foundation for the Accreditation of Cellular Therapy (FACT) for demonstrating compliance with the FACT-JACIE International Standards for the full scope of bone marrow transplant programming. The accreditation is effective January 2016 for a period of three years.
“Patients with leukemia, lymphoma or other life-threatening disease or other blood disorders need the most effective care to improve and prolong their lives,” said Dr. Todd F. Roberts, Program Director of the Blood and Marrow Transplant Unit and Section of Hematologic Malignancies. “FACT reaccreditation for the program at Roger Williams confirms the excellent care and treatment we are delivering to patients in need of transplant services.”
The FACT accreditation process involved an on-site inspection, which took place in December 2015 and was conducted by inspectors qualified by training and experience in cellular therapy. FACT accreditation is embraced by the overwhelming majority of transplant programs. More than 90% in the United States are FACT accredited.
Since 1994, hundreds of cancer patients from throughout the region have received transplantation services at Roger Williams, home to Rhode Island's only Blood and Marrow Transplantation Program. In this comprehensive transplant center, autologous, allogeneic (related and unrelated) and cord blood transplantation services are offered.
A dedicated unit located in the hospital is supplied with high-efficiency particulate air-filtration systems that provide protection to patients who cannot resist infection. Patients are monitored through a centralized intensive care patient monitoring system, which includes highly skilled nurses who have expertise in high-dose, anti-tumor chemotherapy administration and management of transplant-related side effects.
The unit is a full-service program, which provides compassionate care to patients diagnosed with acute and chronic leukemia, lymphoma, multiple myeloma, aplastic anemia, and myelopdysoplastic syndrome.
This voluntary accreditation is based upon compliance with the most comprehensive standards in the field, verified by rigorous peer-reviewed inspections. FACT-accredited organizations voluntarily seek and maintain FACT accreditation through a rigorous process, demonstrating their belief that patient needs are paramount.
The accreditation includes adult allogeneic and autologous transplantation, hematopoietic progenitor cell transplantation, marrow and peripheral blood cellular therapy product processing with minimal manipulation, and cellular therapy product processing with minimal manipulation.
Among the benefits of receiving transplantation services at a FACT-accredited organization:
- Accredited programs have the experience required to understand and provide for the unique needs of hematopoietic progenitor cell (HPC) transplant patients.
- Medical Directors and program personnel meet FACT educational and experience requirements.
- Clinical programs transplant a requisite number of patients annually.
- Collection facilities perform a requisite number of cell collection procedures annually.
- Cell transplantation is performed in accordance with policies for the safe administration of cells as required for optimum patient care.
- Accredited programs utilize processes guided by quality management systems.
- Review, approval, and training requirements ensure processes are appropriate and that personnel understand the duties required of them.
To learn more about the Blood and Marrow Transplantation Program and other cancer services at Roger Williams, please visit: weknowcancer.org